Millennium Management’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
6CM
Millennium Management's ANAB Position: Q3 2026 in Review
Millennium Management reduced its AnaptysBio (ANAB) stake by 2.8% in Q3 2026, selling an estimated $1.29M and leaving 784,560 shares worth $39.4M. The position accounts for 0.01% of the portfolio, ranked #1087.
Millennium Management first reported a position in ANAB in Q1 2017 and has held it in 37 quarters since. The position peaked at $54.5M in Q2 2026. 229 funds tracked by Wall St. Rank hold ANAB as of Q3 2026.
- Millennium Management held 784,560 shares of AnaptysBio worth $39.4M as of Q3 2026.
- Millennium Management sold 22,756 AnaptysBio shares in Q3 2026, an estimated $1.29M.
- AnaptysBio made up 0.01% of Millennium Management's portfolio in Q3 2026, its #1087 holding.
- Millennium Management first reported a position in AnaptysBio in Q1 2017 and has held it in 37 quarters since.
- Millennium Management's AnaptysBio position peaked at $54.5M in Q2 2026.
- 229 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.